Clinical Trials Browser

Phase 4 × Spondylarthritis × Adalimumab × Clear all

NCT02492217 2020-11-03

Biomarkers Identification of Anti-tumor Necrosis Factor (TNF) α Agent's Efficacy in Ankylosing Spondylitis Patients

Phase 4 Completed

Spondylitis, Ankylosing, Spondylarthritis